We acquire regenerative medicine practices across the country and scale them through our national telehealth infrastructure — then push the frontier internationally into gene therapy and age reversal.
Explore the Platform → Connect With UsWe acquire regenerative medicine practices across the United States — from individual clinics to multi-location operators. Each acquisition plugs into our centralized infrastructure, protocols, and telehealth platform, immediately unlocking scale that a standalone practice can't achieve on its own.
Every practice we acquire immediately gains access to our national telehealth infrastructure — extending their reach from a local market to all 50 states overnight. Our platform is the multiplier that makes each acquisition worth more inside our portfolio than it was as a standalone clinic.
With a national platform established, we are expanding internationally into markets at the cutting edge of longevity medicine — gene therapy, epigenetic reprogramming, and age reversal protocols. We go where the most advanced science is moving into clinical practice.
Most medical practice roll-ups stop at the acquisition. We go further. Every clinic we acquire immediately plugs into a national telehealth infrastructure that turns a local practice into a 50-state business.
That's the compounding advantage. The platform gets more powerful with every practice added — and every practice gets more valuable the moment it joins the network.
Acquired clinics plug into a single infrastructure — not a collection of separate businesses. One network, shared across the entire portfolio.
A clinic seeing 200 local patients can now serve patients in 50 states via telehealth — within weeks of joining the platform.
Shared back-office, billing, marketing, and compliance across all locations — overhead drops while revenue scales.
Standardized integration playbook means new acquisitions are live on the platform in weeks, not quarters.
Monitoring and participating in the latest clinical developments in therapeutic gene delivery — partnering with leading researchers and early-stage programs at the forefront of genetic medicine.
Tracking emerging science in epigenetic reprogramming, senolytics, and biological age reversal. We are actively evaluating where these approaches cross from research into patient-applicable therapy.
Identifying international markets with progressive regulatory frameworks that enable access to advanced regenerative and longevity therapies before they reach broader availability domestically.
Building relationships with the leading clinics, researchers, and operators in longevity medicine worldwide — creating the network that positions our platform at the center of this emerging field.
We are actively acquiring regenerative medicine practices nationwide. If you're a clinic owner exploring a transition, a partner looking to join the network, or an investor interested in the platform — send us a message below.
📅 Get in Touch — Book a Call